|
AG-013736
AG-013736
information and resources from the National Cancer Institute
NCI Thesaurus | AG-013736
An orally bioavailable tyrosine kinase inhibitor. AG-013736 inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF), thereby exerting an anti-angiogenic effect. NCI Thesaurus | AG-013736
An orally bioavailable tyrosine kinase inhibitor. AG-013736 inhibits the proangiogenic cytokines vascular endothelial growth factor (VEGF) and platelet-derived growth factor receptor (PDGF), thereby exerting an anti-angiogenic effect.
|
|
|
|
|
|
AG-013736
-->
|
